Emerging Infectious Diseases (Feb 2017)

Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, Israel

  • Ronen Ben-Ami,
  • Judith Berman,
  • Ana Novikov,
  • Edna Bash,
  • Yael Shachor-Meyouhas,
  • Shiri Zakin,
  • Yasmin Maor,
  • Jalal Tarabia,
  • Vered Schechner,
  • Amos Adler,
  • Talya Finn

DOI
https://doi.org/10.3201/eid2302.161486
Journal volume & issue
Vol. 23, no. 2
pp. 195 – 203

Abstract

Read online

Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel. C. auris was isolated in 5 patients with nosocomial bloodstream infection, and C. haemulonii was found as a colonizer of leg wounds at a peripheral vascular disease clinic. Liberal use of topical miconazole and close contact among patients were implicated in C. haemulonii transmission. C. auris exhibited higher thermotolerance, virulence in a mouse infection model, and ATP-dependent drug efflux activity than C. haemulonii. Comparison of ribosomal DNA sequences found that C. auris strains from Israel were phylogenetically distinct from isolates from East Asia, South Africa and Kuwait, whereas C. haemulonii strains from different countries were closely interrelated. Our findings highlight the pathogenicity of C. auris and underscore the need to limit its spread.

Keywords